| 1 | [ | 92,097 |
| 2 | italiana | 17 |
| 3 | 95-percent | 5 |
| 4 | bmc-lm | 5 |
| 5 | mmol/8 | 4 |
| 6 | rr/min | 3 |
| 7 | .their | 2 |
| 8 | /predicted | 2 |
| 9 | 0.81-log | 2 |
| 10 | 2.2kg | 2 |
| 11 | 6.8- | 2 |
| 12 | cigarettes/48 | 2 |
| 13 | dimethylcarbamates | 2 |
| 14 | enzymun | 2 |
| 15 | fructose+lipids | 2 |
| 16 | g/cp | 2 |
| 17 | isoxazolidine | 2 |
| 18 | liamat | 2 |
| 19 | month/delivery | 2 |
| 20 | ng/microgram | 2 |
| 21 | nt-3-transfected | 2 |
| 22 | plr2-δ | 2 |
| 23 | post-discharged | 2 |
| 24 | s100a12/srage | 2 |
| 25 | shī | 2 |
| 26 | +rest | 1 |
| 27 | -0.44-0.37 | 1 |
| 28 | -12.30 | 1 |
| 29 | -16.20 | 1 |
| 30 | -161.60 | 1 |
| 31 | -1h-isoindol-3-amine | 1 |
| 32 | -2,83 | 1 |
| 33 | -2-oxo- | 1 |
| 34 | -2.4l | 1 |
| 35 | -21.97 | 1 |
| 36 | -50,40 | 1 |
| 37 | -ene-6-o-β | 1 |
| 38 | -spirost-5-en-3 | 1 |
| 39 | //links.lww.com/cospc/a6 | 1 |
| 40 | 0.1.07 | 1 |
| 41 | 0.24-1.87 | 1 |
| 42 | 0.28- | 1 |
| 43 | 0.45– | 1 |
| 44 | 0.55– | 1 |
| 45 | 0.70-1.48 | 1 |
| 46 | 0/7-32 | 1 |
| 47 | 0·844 | 1 |
| 48 | 1,166.9 | 1 |
| 49 | 1,319.6 | 1 |
| 50 | 1,509.7 | 1 |
| 51 | 1.4529 | 1 |
| 52 | 10.12±3.62 | 1 |
| 53 | 1138.88±490.10 | 1 |
| 54 | 1283.85±439.87 | 1 |
| 55 | 13.38±7.60 | 1 |
| 56 | 13.78±6.71 | 1 |
| 57 | 1377,614.93±93.44 | 1 |
| 58 | 15-ketoprostaglandin | 1 |
| 59 | 19,667,062-24,401,876 | 1 |
| 60 | 1:0.16 | 1 |
| 61 | 2.35±0.32 | 1 |
| 62 | 21.6- | 1 |
| 63 | 22.4- | 1 |
| 64 | 22033-26033/ncic | 1 |
| 65 | 230-290 | 1 |
| 66 | 27.9- | 1 |
| 67 | 289.5 | 1 |
| 68 | 3.0/ml/mm | 1 |
| 69 | 309.6±81 | 1 |
| 70 | 33.355±12.373 | 1 |
| 71 | 37,430 | 1 |
| 72 | 38±20.4 | 1 |
| 73 | 4,827 | 1 |
| 74 | 4-producing | 1 |
| 75 | 4.291 | 1 |
| 76 | 4·256 | 1 |
| 77 | 5.861 | 1 |
| 78 | 52.9l | 1 |
| 79 | 54+/-5 | 1 |
| 80 | 6·87 | 1 |
| 81 | 7.2088 | 1 |
| 82 | 8.52±7.96 | 1 |
| 83 | 80.9-90.7 | 1 |
| 84 | 867,270.59±49 | 1 |
| 85 | 94+/-1 | 1 |
| 86 | 9rr0 | 1 |
| 87 | a-tvi/tvi | 1 |
| 88 | acetate-stimulated | 1 |
| 89 | amino-2-deoxy- | 1 |
| 90 | analogues-associated | 1 |
| 91 | antalarmin-induced | 1 |
| 92 | aor,1.8 | 1 |
| 93 | bythe | 1 |
| 94 | caffeine-elicited | 1 |
| 95 | chtricam-p | 1 |
| 96 | chylomicron-pon1/chylomicron-triacylglycerides | 1 |
| 97 | complex/simple | 1 |
| 98 | ccc6 | 1 |
| 99 | dmft/0.11 | 1 |
| 100 | eaux | 1 |
| 101 | f/kryptofix | 1 |
| 102 | g-156 | 1 |
| 103 | galactosyl/agalactosyl | 1 |
| 104 | go-go | 1 |
| 105 | h7-specific | 1 |
| 106 | hcvrna | 1 |
| 107 | heraenium | 1 |
| 108 | hoover | 1 |
| 109 | hydrol | 1 |
| 110 | il-4/ | 1 |
| 111 | jahua | 1 |
| 112 | jeunes | 1 |
| 113 | kcl-stimulated | 1 |
| 114 | kfile | 1 |
| 115 | l'ethnopharmacologie | 1 |
| 116 | l'énergie | 1 |
| 117 | lactis-supplemented | 1 |
| 118 | lesion-to-normal-liver | 1 |
| 119 | max/°c | 1 |
| 120 | mean-absolute | 1 |
| 121 | msper | 1 |
| 122 | nmol/kg/day | 1 |
| 123 | nnt3 | 1 |
| 124 | non-attenuation | 1 |
| 125 | non-decay | 1 |
| 126 | non-punitive | 1 |
| 127 | nèi | 1 |
| 128 | one-sided-test-based | 1 |
| 129 | plus≥5 | 1 |
| 130 | pound47 | 1 |
| 131 | propanaminium | 1 |
| 132 | propped | 1 |
| 133 | qt-time | 1 |
| 134 | r2/eta | 1 |
| 135 | rates-time | 1 |
| 136 | rct=10 | 1 |
| 137 | rct=11 | 1 |
| 138 | rct=13 | 1 |
| 139 | rct=2 | 1 |
| 140 | rcts=2 | 1 |
| 141 | rcts=8 | 1 |
| 142 | ready-prep | 1 |
| 143 | reduction=0.31 | 1 |
| 144 | rr1.00 | 1 |
| 145 | rr1.88 | 1 |
| 146 | rr1.99 | 1 |
| 147 | s-poor | 1 |
| 148 | sdh2/sdd2 | 1 |
| 149 | tissue-between | 1 |
| 150 | to127 | 1 |
| 151 | transcripts/microg | 1 |
| 152 | trg/1 | 1 |
| 153 | two-sided-test-based | 1 |
| 154 | uptake-evoked | 1 |
| 155 | variability/mean | 1 |
| 156 | walsbyi | 1 |
| 157 | wedebicoside | 1 |
| 158 | α≤0.01 | 1 |
| 159 | δecc | 1 |
| 160 | μm/diopters | 1 |
| 161 | €107-199/cad | 1 |
| 162 | ≥3.7 | 1 |
| 1 | +rest | 1 |
| 2 | -0.44-0.37 | 1 |
| 3 | -12.30 | 1 |
| 4 | -16.20 | 1 |
| 5 | -161.60 | 1 |
| 6 | -1h-isoindol-3-amine | 1 |
| 7 | -2,83 | 1 |
| 8 | -2-oxo- | 1 |
| 9 | -2.4l | 1 |
| 10 | -21.97 | 1 |
| 11 | -50,40 | 1 |
| 12 | -ene-6-o-β | 1 |
| 13 | -spirost-5-en-3 | 1 |
| 14 | .their | 2 |
| 15 | //links.lww.com/cospc/a6 | 1 |
| 16 | /predicted | 2 |
| 17 | 0.1.07 | 1 |
| 18 | 0.24-1.87 | 1 |
| 19 | 0.28- | 1 |
| 20 | 0.45– | 1 |
| 21 | 0.55– | 1 |
| 22 | 0.70-1.48 | 1 |
| 23 | 0.81-log | 2 |
| 24 | 0/7-32 | 1 |
| 25 | 0·844 | 1 |
| 26 | 1,166.9 | 1 |
| 27 | 1,319.6 | 1 |
| 28 | 1,509.7 | 1 |
| 29 | 1.4529 | 1 |
| 30 | 10.12±3.62 | 1 |
| 31 | 1138.88±490.10 | 1 |
| 32 | 1283.85±439.87 | 1 |
| 33 | 13.38±7.60 | 1 |
| 34 | 13.78±6.71 | 1 |
| 35 | 1377,614.93±93.44 | 1 |
| 36 | 15-ketoprostaglandin | 1 |
| 37 | 19,667,062-24,401,876 | 1 |
| 38 | 1:0.16 | 1 |
| 39 | 2.2kg | 2 |
| 40 | 2.35±0.32 | 1 |
| 41 | 21.6- | 1 |
| 42 | 22.4- | 1 |
| 43 | 22033-26033/ncic | 1 |
| 44 | 230-290 | 1 |
| 45 | 27.9- | 1 |
| 46 | 289.5 | 1 |
| 47 | 3.0/ml/mm | 1 |
| 48 | 309.6±81 | 1 |
| 49 | 33.355±12.373 | 1 |
| 50 | 37,430 | 1 |
| 51 | 38±20.4 | 1 |
| 52 | 4,827 | 1 |
| 53 | 4-producing | 1 |
| 54 | 4.291 | 1 |
| 55 | 4·256 | 1 |
| 56 | 5.861 | 1 |
| 57 | 52.9l | 1 |
| 58 | 54+/-5 | 1 |
| 59 | 6.8- | 2 |
| 60 | 6·87 | 1 |
| 61 | 7.2088 | 1 |
| 62 | 8.52±7.96 | 1 |
| 63 | 80.9-90.7 | 1 |
| 64 | 867,270.59±49 | 1 |
| 65 | 94+/-1 | 1 |
| 66 | 95-percent | 5 |
| 67 | 9rr0 | 1 |
| 68 | [ | 92,097 |
| 69 | a-tvi/tvi | 1 |
| 70 | acetate-stimulated | 1 |
| 71 | amino-2-deoxy- | 1 |
| 72 | analogues-associated | 1 |
| 73 | antalarmin-induced | 1 |
| 74 | aor,1.8 | 1 |
| 75 | bmc-lm | 5 |
| 76 | bythe | 1 |
| 77 | caffeine-elicited | 1 |
| 78 | chtricam-p | 1 |
| 79 | chylomicron-pon1/chylomicron-triacylglycerides | 1 |
| 80 | cigarettes/48 | 2 |
| 81 | complex/simple | 1 |
| 82 | ccc6 | 1 |
| 83 | dimethylcarbamates | 2 |
| 84 | dmft/0.11 | 1 |
| 85 | eaux | 1 |
| 86 | enzymun | 2 |
| 87 | f/kryptofix | 1 |
| 88 | fructose+lipids | 2 |
| 89 | g-156 | 1 |
| 90 | g/cp | 2 |
| 91 | galactosyl/agalactosyl | 1 |
| 92 | go-go | 1 |
| 93 | h7-specific | 1 |
| 94 | hcvrna | 1 |
| 95 | heraenium | 1 |
| 96 | hoover | 1 |
| 97 | hydrol | 1 |
| 98 | il-4/ | 1 |
| 99 | isoxazolidine | 2 |
| 100 | italiana | 17 |
| 101 | jahua | 1 |
| 102 | jeunes | 1 |
| 103 | kcl-stimulated | 1 |
| 104 | kfile | 1 |
| 105 | l'ethnopharmacologie | 1 |
| 106 | l'énergie | 1 |
| 107 | lactis-supplemented | 1 |
| 108 | lesion-to-normal-liver | 1 |
| 109 | liamat | 2 |
| 110 | max/°c | 1 |
| 111 | mean-absolute | 1 |
| 112 | mmol/8 | 4 |
| 113 | month/delivery | 2 |
| 114 | msper | 1 |
| 115 | ng/microgram | 2 |
| 116 | nmol/kg/day | 1 |
| 117 | nnt3 | 1 |
| 118 | non-attenuation | 1 |
| 119 | non-decay | 1 |
| 120 | non-punitive | 1 |
| 121 | nt-3-transfected | 2 |
| 122 | nèi | 1 |
| 123 | one-sided-test-based | 1 |
| 124 | plr2-δ | 2 |
| 125 | plus≥5 | 1 |
| 126 | post-discharged | 2 |
| 127 | pound47 | 1 |
| 128 | propanaminium | 1 |
| 129 | propped | 1 |
| 130 | qt-time | 1 |
| 131 | r2/eta | 1 |
| 132 | rates-time | 1 |
| 133 | rct=10 | 1 |
| 134 | rct=11 | 1 |
| 135 | rct=13 | 1 |
| 136 | rct=2 | 1 |
| 137 | rcts=2 | 1 |
| 138 | rcts=8 | 1 |
| 139 | ready-prep | 1 |
| 140 | reduction=0.31 | 1 |
| 141 | rr/min | 3 |
| 142 | rr1.00 | 1 |
| 143 | rr1.88 | 1 |
| 144 | rr1.99 | 1 |
| 145 | s-poor | 1 |
| 146 | s100a12/srage | 2 |
| 147 | sdh2/sdd2 | 1 |
| 148 | shī | 2 |
| 149 | tissue-between | 1 |
| 150 | to127 | 1 |
| 151 | transcripts/microg | 1 |
| 152 | trg/1 | 1 |
| 153 | two-sided-test-based | 1 |
| 154 | uptake-evoked | 1 |
| 155 | variability/mean | 1 |
| 156 | walsbyi | 1 |
| 157 | wedebicoside | 1 |
| 158 | α≤0.01 | 1 |
| 159 | δecc | 1 |
| 160 | μm/diopters | 1 |
| 161 | €107-199/cad | 1 |
| 162 | ≥3.7 | 1 |
| 1 | 22.4- | 1 |
| 2 | 21.6- | 1 |
| 3 | 6.8- | 2 |
| 4 | 0.28- | 1 |
| 5 | 27.9- | 1 |
| 6 | -2-oxo- | 1 |
| 7 | amino-2-deoxy- | 1 |
| 8 | il-4/ | 1 |
| 9 | rr1.00 | 1 |
| 10 | 1138.88±490.10 | 1 |
| 11 | rct=10 | 1 |
| 12 | -16.20 | 1 |
| 13 | -12.30 | 1 |
| 14 | 37,430 | 1 |
| 15 | -50,40 | 1 |
| 16 | -161.60 | 1 |
| 17 | 13.38±7.60 | 1 |
| 18 | 230-290 | 1 |
| 19 | 9rr0 | 1 |
| 20 | 94+/-1 | 1 |
| 21 | trg/1 | 1 |
| 22 | α≤0.01 | 1 |
| 23 | dmft/0.11 | 1 |
| 24 | rct=11 | 1 |
| 25 | reduction=0.31 | 1 |
| 26 | 5.861 | 1 |
| 27 | 13.78±6.71 | 1 |
| 28 | 309.6±81 | 1 |
| 29 | 4.291 | 1 |
| 30 | 0/7-32 | 1 |
| 31 | 2.35±0.32 | 1 |
| 32 | 10.12±3.62 | 1 |
| 33 | rcts=2 | 1 |
| 34 | rct=2 | 1 |
| 35 | sdh2/sdd2 | 1 |
| 36 | -spirost-5-en-3 | 1 |
| 37 | rct=13 | 1 |
| 38 | 33.355±12.373 | 1 |
| 39 | -2,83 | 1 |
| 40 | nnt3 | 1 |
| 41 | 38±20.4 | 1 |
| 42 | 1377,614.93±93.44 | 1 |
| 43 | 0·844 | 1 |
| 44 | 54+/-5 | 1 |
| 45 | 289.5 | 1 |
| 46 | plus≥5 | 1 |
| 47 | 1,319.6 | 1 |
| 48 | 1:0.16 | 1 |
| 49 | g-156 | 1 |
| 50 | 4·256 | 1 |
| 51 | 19,667,062-24,401,876 | 1 |
| 52 | 8.52±7.96 | 1 |
| 53 | //links.lww.com/cospc/a6 | 1 |
| 54 | ccc6 | 1 |
| 55 | 80.9-90.7 | 1 |
| 56 | ≥3.7 | 1 |
| 57 | 1,509.7 | 1 |
| 58 | 0.1.07 | 1 |
| 59 | to127 | 1 |
| 60 | 4,827 | 1 |
| 61 | -0.44-0.37 | 1 |
| 62 | pound47 | 1 |
| 63 | 0.24-1.87 | 1 |
| 64 | 1283.85±439.87 | 1 |
| 65 | 6·87 | 1 |
| 66 | -21.97 | 1 |
| 67 | aor,1.8 | 1 |
| 68 | mmol/8 | 4 |
| 69 | 0.70-1.48 | 1 |
| 70 | cigarettes/48 | 2 |
| 71 | rr1.88 | 1 |
| 72 | 7.2088 | 1 |
| 73 | rcts=8 | 1 |
| 74 | 1,166.9 | 1 |
| 75 | 1.4529 | 1 |
| 76 | 867,270.59±49 | 1 |
| 77 | rr1.99 | 1 |
| 78 | [ | 92,097 |
| 79 | italiana | 17 |
| 80 | hcvrna | 1 |
| 81 | r2/eta | 1 |
| 82 | jahua | 1 |
| 83 | δecc | 1 |
| 84 | 22033-26033/ncic | 1 |
| 85 | h7-specific | 1 |
| 86 | max/°c | 1 |
| 87 | €107-199/cad | 1 |
| 88 | antalarmin-induced | 1 |
| 89 | post-discharged | 2 |
| 90 | uptake-evoked | 1 |
| 91 | propped | 1 |
| 92 | one-sided-test-based | 1 |
| 93 | two-sided-test-based | 1 |
| 94 | analogues-associated | 1 |
| 95 | acetate-stimulated | 1 |
| 96 | kcl-stimulated | 1 |
| 97 | nt-3-transfected | 2 |
| 98 | /predicted | 2 |
| 99 | caffeine-elicited | 1 |
| 100 | lactis-supplemented | 1 |
| 101 | wedebicoside | 1 |
| 102 | s100a12/srage | 2 |
| 103 | bythe | 1 |
| 104 | l'ethnopharmacologie | 1 |
| 105 | l'énergie | 1 |
| 106 | kfile | 1 |
| 107 | complex/simple | 1 |
| 108 | rates-time | 1 |
| 109 | qt-time | 1 |
| 110 | isoxazolidine | 2 |
| 111 | -1h-isoindol-3-amine | 1 |
| 112 | mean-absolute | 1 |
| 113 | non-punitive | 1 |
| 114 | 2.2kg | 2 |
| 115 | 4-producing | 1 |
| 116 | 0.81-log | 2 |
| 117 | transcripts/microg | 1 |
| 118 | a-tvi/tvi | 1 |
| 119 | walsbyi | 1 |
| 120 | nèi | 1 |
| 121 | -2.4l | 1 |
| 122 | 52.9l | 1 |
| 123 | hydrol | 1 |
| 124 | galactosyl/agalactosyl | 1 |
| 125 | ng/microgram | 2 |
| 126 | bmc-lm | 5 |
| 127 | 3.0/ml/mm | 1 |
| 128 | heraenium | 1 |
| 129 | propanaminium | 1 |
| 130 | variability/mean | 1 |
| 131 | tissue-between | 1 |
| 132 | 15-ketoprostaglandin | 1 |
| 133 | rr/min | 3 |
| 134 | non-attenuation | 1 |
| 135 | enzymun | 2 |
| 136 | go-go | 1 |
| 137 | chtricam-p | 1 |
| 138 | g/cp | 2 |
| 139 | ready-prep | 1 |
| 140 | msper | 1 |
| 141 | lesion-to-normal-liver | 1 |
| 142 | hoover | 1 |
| 143 | .their | 2 |
| 144 | s-poor | 1 |
| 145 | fructose+lipids | 2 |
| 146 | chylomicron-pon1/chylomicron-triacylglycerides | 1 |
| 147 | jeunes | 1 |
| 148 | dimethylcarbamates | 2 |
| 149 | μm/diopters | 1 |
| 150 | liamat | 2 |
| 151 | 95-percent | 5 |
| 152 | +rest | 1 |
| 153 | f/kryptofix | 1 |
| 154 | eaux | 1 |
| 155 | non-decay | 1 |
| 156 | nmol/kg/day | 1 |
| 157 | month/delivery | 2 |
| 158 | 0.45– | 1 |
| 159 | 0.55– | 1 |
| 160 | shī | 2 |
| 161 | -ene-6-o-β | 1 |
| 162 | plr2-δ | 2 |